217 related articles for article (PubMed ID: 34418761)
1. A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study.
Lillig R; Ophey A; Schulz JB; Reetz K; Wojtala J; Storch A; Liepelt-Scarfone I; Becker S; Berg D; Balzer-Geldsetzer M; Kassubek J; Hilker-Roggendorf R; Witt K; Mollenhauer B; Trenkwalder C; Roeske S; Wittchen HU; Riedel O; Dodel R; Kalbe E
Parkinsonism Relat Disord; 2021 Sep; 90():90-97. PubMed ID: 34418761
[TBL] [Abstract][Full Text] [Related]
2. Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
Camargo CHF; Bronzini A; Tolentino ES; Medyk C; Schultz-Pereira GL
Arq Neuropsiquiatr; 2018 Mar; 76(3):145-149. PubMed ID: 29809231
[TBL] [Abstract][Full Text] [Related]
3. CERAD test performance and cognitive impairment in Parkinson's disease.
Karrasch M; Laatu S; Martikainen K; Marttila R
Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
[TBL] [Abstract][Full Text] [Related]
4. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
[TBL] [Abstract][Full Text] [Related]
5. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals.
Müller S; Herde L; Preische O; Zeller A; Heymann P; Robens S; Elbing U; Laske C
Sci Rep; 2019 Mar; 9(1):3543. PubMed ID: 30837580
[TBL] [Abstract][Full Text] [Related]
7. Education-corrected CERAD identifies MCI and dementia in Parkinson's disease.
Karrasch M; Laatu S; Ellfolk U; Marttila R; Martikainen K
Acta Neurol Scand; 2015 Apr; 131(4):219-24. PubMed ID: 25273524
[TBL] [Abstract][Full Text] [Related]
8. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
Cammisuli DM; Sportiello MT
Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
[TBL] [Abstract][Full Text] [Related]
9. Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies.
Seo EH; Lee DY; Lee JH; Choo IH; Kim JW; Kim SG; Park SY; Shin JH; Do YJ; Yoon JC; Jhoo JH; Kim KW; Woo JI
Am J Geriatr Psychiatry; 2010 Sep; 18(9):801-9. PubMed ID: 20220577
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.
Biundo R; Weis L; Pilleri M; Facchini S; Formento-Dojot P; Vallelunga A; Antonini A
J Neural Transm (Vienna); 2013 Apr; 120(4):627-33. PubMed ID: 23483334
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of a Tablet Computer-Based Cognitive Screening Test for Identification of Amnestic Mild Cognitive Impairment.
Na S; Lee ES; Lee TK
J Korean Med Sci; 2023 May; 38(17):e131. PubMed ID: 37128875
[TBL] [Abstract][Full Text] [Related]
13. A parsimonious scoring and normative calculator for the Parkinson's disease mild cognitive impairment battery.
Bezdicek O; Sulc Z; Nikolai T; Stepankova H; Kopecek M; Jech R; Růžička E
Clin Neuropsychol; 2017; 31(6-7):1231-1247. PubMed ID: 28276860
[TBL] [Abstract][Full Text] [Related]
14. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
[TBL] [Abstract][Full Text] [Related]
15. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
[TBL] [Abstract][Full Text] [Related]
17. Frontal Assessment Battery in Parkinson's Disease: Validity and Morphological Correlates.
Bezdicek O; Růžička F; Fendrych Mazancova A; Roth J; Dušek P; Mueller K; Růžička E; Jech R
J Int Neuropsychol Soc; 2017 Sep; 23(8):675-684. PubMed ID: 28716165
[TBL] [Abstract][Full Text] [Related]
18. Verbal memory declines more in female patients with Parkinson's disease: the importance of gender-corrected normative data.
Fengler S; Roeske S; Heber I; Reetz K; Schulz JB; Riedel O; Wittchen HU; Storch A; Linse K; Baudrexel S; Hilker R; Mollenhauer B; Witt K; Schmidt N; Balzer-Geldsetzer M; Dams J; Dodel R; Gräber S; Pilotto A; Petrelli A; Fünkele S; Kassubek J; Kalbe E
Psychol Med; 2016 Aug; 46(11):2275-86. PubMed ID: 27193073
[TBL] [Abstract][Full Text] [Related]
19. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study.
Paajanen T; Hänninen T; Tunnard C; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H; Addneuromed Consortium
J Alzheimers Dis; 2010; 22(4):1089-97. PubMed ID: 20930314
[TBL] [Abstract][Full Text] [Related]
20. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
